Article
Results of a multigene panel testing approach targeting patients with suspected genetic predisposition to pancreatic ductal adenocarcinoma.
European journal of human genetics : EJHG - 1 Sept 2026
Buecher Bruno, Warcoin Mathilde, Rolland Emilie, Abdullazoda Rukhshona, Le Guillevic Aurélia, Colas Chrystelle, Golmard Lisa
Abstract excerpt
Pancreatic ductal adenocarcinoma occur in the context of a suspected or proven genetic predisposition in 5-10% of cases. While universal germline multigene panel testing is currently recommended by NCCN and ASCO, this approach was previously limited to patients with personal and/or family criteria suggestive of hereditary predisposition. We report the results of this « selective » approach applied in our...
Read the complete abstract on PubMedTopics
- Humans
- Carcinoma, Pancreatic Ductal
- Genetic Predisposition to Disease
- Female
- Pancreatic Neoplasms
